LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 85 of 166
Next
>>
>
2101 to 2125 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	CP466722	0.04	uM	LJP5	72	hr	1097	4112	3846	1.0702	1.0768
BT-20	CP466722	0.12	uM	LJP5	72	hr	1097	4048	3846	1.0535	1.0582
BT-20	CP466722	0.37	uM	LJP5	72	hr	1097	3786	3846	0.9853	0.9837
BT-20	CP466722	1.11	uM	LJP5	72	hr	1097	3862	3846	1.0045	1.0051
BT-20	CP466722	3.33	uM	LJP5	72	hr	1097	3520	3846	0.9156	0.9050
BT-20	CP466722	10	uM	LJP5	72	hr	1097	2013	3846	0.5228	0.3965
BT-20	CP724714	0.04	uM	LJP5	72	hr	1097	3635	3846	0.9455	0.9391
BT-20	CP724714	0.12	uM	LJP5	72	hr	1097	3658	3846	0.9512	0.9453
BT-20	CP724714	0.37	uM	LJP5	72	hr	1097	3643	3846	0.9478	0.9419
BT-20	CP724714	1.11	uM	LJP5	72	hr	1097	3148	3846	0.8192	0.7904
BT-20	CP724714	3.33	uM	LJP5	72	hr	1097	2909	3846	0.7563	0.7133
BT-20	CP724714	10	uM	LJP5	72	hr	1097	2233	3846	0.5792	0.4746
BT-20	Alvocidib	0.04	uM	LJP6	72	hr	1097	1075	3673	0.2930	-0.0116
BT-20	Alvocidib	0.12	uM	LJP6	72	hr	1097	613	3673	0.1671	-0.2836
BT-20	Alvocidib	0.37	uM	LJP6	72	hr	1097	611	3673	0.1664	-0.2853
BT-20	Alvocidib	1.11	uM	LJP6	72	hr	1097	612	3673	0.1664	-0.2857
BT-20	Alvocidib	3.33	uM	LJP6	72	hr	1097	635	3673	0.1731	-0.2694
BT-20	Alvocidib	10	uM	LJP6	72	hr	1097	586	3673	0.1596	-0.3025
BT-20	GW843682X	0.04	uM	LJP6	72	hr	1097	3006	3673	0.8188	0.7820
BT-20	GW843682X	0.12	uM	LJP6	72	hr	1097	2174	3673	0.5918	0.4792
BT-20	GW843682X	0.37	uM	LJP6	72	hr	1097	1471	3673	0.4008	0.1835
BT-20	GW843682X	1.11	uM	LJP6	72	hr	1097	1003	3673	0.2730	-0.0505
BT-20	GW843682X	3.33	uM	LJP6	72	hr	1097	992	3673	0.2702	-0.0567
BT-20	GW843682X	10	uM	LJP6	72	hr	1097	1622	3673	0.4425	0.2500
BT-20	HG-5-113-01	0.04	uM	LJP5	72	hr	1097	3850	3846	1.0008	1.0003

|<
<<
Previous
Page 85 of 166
Next
>>
>
2101 to 2125 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)